ReviewJournal of clinical medicine2020

Could Mesenchymal Stem Cell-Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients?

Chiara Gardin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.